Marijuana use is directly associated with both symptom mitigation and a reduction in prescription drugs in those with MS (multiple sclerosis), according to a new study published in the journal Neurology and epublished by the U.S. National Institute of Health.
“The purpose of this study was to investigate the role of medical cannabis in improving symptomatology in patients diagnosed with multiple sclerosis (MS)”, states the study’s abstract. “We also sought to collect data on other pertinent outcomes related to the use of cannabis to enhance understanding of the potential benefits this complementary therapy offers.”
For the study, “A retrospective chart review of 77 patients diagnosed with multiple sclerosis participating in treatment with medical cannabis for symptom management was conducted (F=53, M=24, Mean Age=49±12). A variety of objective and subjective variables that pertain to alleviation of MS symptoms were collected from each of the first four appointments following initiation of medical cannabis.” In addition, “A cross-sectional review of self-rating scales completed by patients was also conducted to determine gross changes in mental health.”
Researchers found that “Patients with multiple sclerosis who initiated medical cannabis treatment experienced improved symptomology with good tolerability and were able to decrease or altogether discontinue